Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2012-05-02 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ALTKIRCH (68130), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
4A-CADUCEE PHARMACIE DU SUNDGAU : revenue, balance sheet and financial ratios
4A-CADUCEE PHARMACIE DU SUNDGAU is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ALTKIRCH (68130),
this company of category PME
shows in 2025 a net income positive of 34 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - 4A-CADUCEE PHARMACIE DU SUNDGAU (SIREN 751384983)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
33 679 €
65 539 €
50 597 €
134 800 €
-5 942 €
46 772 €
49 554 €
50 886 €
49 384 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, 4A-CADUCEE PHARMACIE DU SUNDGAU generates positive net income of 34 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 49 k€ -> 34 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
33 679 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
45.85%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
55.866%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution 4A-CADUCEE PHARMACIE DU SUNDGAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
225.076
183.204
147.818
119.289
156.841
115.151
85.25
62.946
45.85
Financial autonomy
27.996
32.044
36.935
40.794
34.315
38.651
45.415
50.443
55.866
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
45.852025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-7 pts over 3 years
In 2025, the debt ratio of 4A-CADUCEE PHARMACIE DU S... (45.85) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
55.87%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good+7 pts over 3 years
In 2025, the financial autonomy of 4A-CADUCEE PHARMACIE DU S... (55.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 128.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
128.72
Liquidity indicators evolution 4A-CADUCEE PHARMACIE DU SUNDGAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
159.545
192.525
216.912
192.161
201.225
66.753
189.124
151.934
128.72
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
128.722025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-25 pts over 3 years
In 2025, the liquidity ratio of 4A-CADUCEE PHARMACIE DU S... (128.72) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of 4A-CADUCEE PHARMACIE DU SUNDGAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of 4A-CADUCEE PHARMACIE DU SUNDGAU is estimated at
534 994 €
(range 363 050€ - 839 480€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
363k€534k€839k€
534 994 €Range: 363 050€ - 839 480€
NAF 5 année 2025
Valuation method used
Net Income Multiple
33 679 €
×
15.9x
=534 995 €
Range: 363 050€ - 839 481€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare 4A-CADUCEE PHARMACIE DU SUNDGAU with other companies in the same sector:
Frequently asked questions about 4A-CADUCEE PHARMACIE DU SUNDGAU
What is the revenue of 4A-CADUCEE PHARMACIE DU SUNDGAU ?
The revenue of 4A-CADUCEE PHARMACIE DU SUNDGAU is not publicly disclosed (confidential accounts filed with INPI).
Is 4A-CADUCEE PHARMACIE DU SUNDGAU profitable?
Yes, 4A-CADUCEE PHARMACIE DU SUNDGAU generated a net profit of 34 k€ in 2025.
Where is the headquarters of 4A-CADUCEE PHARMACIE DU SUNDGAU ?
The headquarters of 4A-CADUCEE PHARMACIE DU SUNDGAU is located in ALTKIRCH (68130), in the department Haut-Rhin.
Where to find the tax return of 4A-CADUCEE PHARMACIE DU SUNDGAU ?
The tax return of 4A-CADUCEE PHARMACIE DU SUNDGAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does 4A-CADUCEE PHARMACIE DU SUNDGAU operate?
4A-CADUCEE PHARMACIE DU SUNDGAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart